Decrease Furosemide (Lasix), Not Spironolactone
In a patient on both furosemide and spironolactone for hypertension, you should reduce or discontinue the furosemide, as spironolactone is the superior agent for blood pressure control and should be maintained as the preferred diuretic in this setting.
Rationale Based on Evidence Hierarchy
Guideline-Based Approach
The 2025 AHA/ACC hypertension guidelines clearly establish spironolactone as the preferred fourth-line agent for resistant hypertension, specifically recommending the combination of ACE inhibitor or ARB + CCB + thiazide-like diuretics, with spironolactone added when blood pressure remains uncontrolled 1. Loop diuretics like furosemide are not mentioned as preferred agents in the standard resistant hypertension algorithm.
FDA Labeling Considerations
The Lasix (furosemide) FDA label indicates that for hypertension, the usual dose is 80mg daily (divided as 40mg twice daily), and importantly states: "As the blood pressure falls under the potentiating effect of LASIX, a further reduction in dosage or even discontinuation of other antihypertensive drugs may be necessary" 2. This directly supports reducing furosemide when blood pressure control improves or when optimizing the antihypertensive regimen.
Clinical Evidence Supporting Spironolactone Superiority
Multiple high-quality studies demonstrate spironolactone's superior efficacy:
Head-to-head comparison: In a randomized trial comparing spironolactone 25mg versus furosemide 40mg in resistant hypertension, spironolactone reduced systolic BP by 24 mmHg versus only 13.8 mmHg with furosemide (P<0.01), and diastolic BP by 11 mmHg versus 5.2 mmHg (P<0.01) at 6 months 3.
Long-term renal protection: Spironolactone was associated with slower CKD progression (-2.1 ml/min/1.73m² annual eGFR decline) compared to furosemide (-3.2 ml/min/1.73m² decline), along with significant albuminuria reduction 4.
Large observational data: The ASCOT-BPLA analysis of 1,411 patients showed spironolactone (median 25mg) reduced BP by 21.9/9.5 mmHg when added as fourth-line therapy 5.
Practical Implementation Algorithm
Step 1: Verify the indication
- If treating resistant hypertension → maintain spironolactone, reduce furosemide
- If treating volume overload/edema → different considerations apply (this question specifically addresses hypertension)
Step 2: Reduce furosemide systematically
- Decrease furosemide by 50% initially (per FDA guidance when optimizing antihypertensive regimens) 2
- Monitor BP closely over 1-2 weeks
- Consider complete discontinuation if BP remains controlled and no volume overload present
Step 3: Maintain spironolactone
- Continue spironolactone at current dose (typically 25-50mg daily)
- Monitor serum potassium and creatinine closely, especially in diabetics 3
Critical Monitoring Parameters
When reducing furosemide:
- Check serum potassium within 1 week (risk increases as furosemide decreases and spironolactone effect predominates)
- Monitor for signs of volume overload (weight gain, edema, dyspnea)
- Assess BP response at 1-2 weeks
Common pitfalls to avoid:
- Do not reduce spironolactone first - it is the more effective antihypertensive agent 3, 4
- Watch for hyperkalemia - the FDA label warns that furosemide combined with ACE inhibitors/ARBs may lead to severe hypotension and renal dysfunction, and dose reduction may be necessary 2. As you reduce the potassium-wasting furosemide while maintaining the potassium-sparing spironolactone, hyperkalemia risk increases
- Monitor renal function - particularly in patients with baseline CKD, diabetes, or elderly patients 3
Special Considerations
The evidence consistently shows spironolactone provides superior BP reduction (average 22/10 mmHg across studies) 6, better renal outcomes 4, and is specifically recommended in current guidelines for resistant hypertension 1. Furosemide, while useful for volume management, is not the preferred diuretic for hypertension control and should be the agent reduced when optimizing therapy.
In patients with both hypertension and significant volume overload, this recommendation may need modification, but for pure hypertension management, furosemide reduction is the appropriate choice.